231 related articles for article (PubMed ID: 18066873)
1. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
[TBL] [Abstract][Full Text] [Related]
2. Ribonucleosides bearing Michael acceptors: synthesis, molecular docking, enzyme inhibition data and antiviral activity.
Nair V; Uchil V; Ma X; Zhu Q; Zhang F; Bonsu E
Nucleic Acids Symp Ser (Oxf); 2008; (52):625-6. PubMed ID: 18776535
[No Abstract] [Full Text] [Related]
3. Base-functionalized carbocyclic nucleosides: design, synthesis, and mechanism of antiviral activity.
Nair V; Zhang F; Ma X; Bonsu E
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):408-23. PubMed ID: 20183592
[TBL] [Abstract][Full Text] [Related]
4. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
5. 2'-Deoxy-2'-C-trifluoromethyl beta-D-ribonucleoside analogues: synthesis and antiviral evaluations.
Jeannot F; Gosselin G; Mathé C
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):857-9. PubMed ID: 14565296
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of 2-functionalized purine nucleosides.
Nair V; Bera B; Kern ER
Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):115-27. PubMed ID: 12744599
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate.
Pal S; Bera B; Nair V
Bioorg Med Chem; 2002 Nov; 10(11):3615-8. PubMed ID: 12213477
[TBL] [Abstract][Full Text] [Related]
8. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
Shu Q; Nair V
Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of inosine monophosphate dehydrogenase: probes for antiviral drug discovery.
Story S; Gupta M; Bonsu E; Nair V
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):717-20. PubMed ID: 16248022
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral evaluation of isatin ribonucleosides.
de Oliveira MR; Torres JC; Garden SJ; dos Santos CV; Alves TR; Pinto AC; Pereira Hde S; Ferreira LR; Moussatché N; Frugulhetti IC; Ferreira VF; de Souza MC
Nucleosides Nucleotides Nucleic Acids; 2002; 21(11-12):825-35. PubMed ID: 12537024
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
Oh CH; Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
[TBL] [Abstract][Full Text] [Related]
13. A three-dimensional pharmacophore model for IMPDH inhibitors.
Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
[TBL] [Abstract][Full Text] [Related]
15. Oxanosine Monophosphate Is a Covalent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase.
Yu R; Kim Y; Maltseva N; Braunstein P; Joachimiak A; Hedstrom L
Chem Res Toxicol; 2019 Mar; 32(3):456-466. PubMed ID: 30746940
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
[TBL] [Abstract][Full Text] [Related]
17. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
[TBL] [Abstract][Full Text] [Related]
18. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
